Insider: BENEVICH ERIC Chief Commercial Officer - NEUROCRINE BIOSCIENCES INC
| Company Holdings |
| Direct | Indirect Ownership | Total | |
| Shares | 44,689 | 0 | 44,689 |
| Value | $6,296,233.21 | $0.00 | $6,296,233.21 |
Trans. Date |
Trans. Type |
Shares |
Ownership Type |
Issue Type |
Price |
Trans. Value |
Total Shares Owned |
|---|---|---|---|---|---|---|---|
| 02/13/2025 | DDS | 1,056 | Direct | COM | $116.71 | $123,244.81 | 44,689 |
| 02/13/2025 | DDS | 1,098 | Direct | COM | $116.74 | $128,182.83 | 43,784 |
| 02/10/2025 | DDS | 980 | Direct | COM | $118.31 | $115,940.37 | 42,799 |
| 01/31/2025 | DDS | 1,207 | Direct | COM | $152.94 | $184,598.58 | 41,919 |
| 04/15/2024 | DDS | 12,587 | Direct | COM | $133.36 | $1,678,660.22 | 40,778 |
| 04/15/2024 | DDS | 7,231 | Direct | COM | $133.36 | $964,359.42 | 40,778 |
| 03/14/2024 | DDS | 5,479 | Direct | COM | $139.38 | $763,656.99 | 40,778 |
| 03/14/2024 | DDS | 69,521 | Direct | COM | $139.38 | $9,689,760.51 | 40,778 |
| 02/28/2024 | DDS | 53,143 | Direct | COM | $134.69 | $7,157,729.70 | 40,616 |
| 02/28/2024 | DDS | 21,857 | Direct | COM | $134.69 | $2,943,877.80 | 40,616 |
| 02/13/2024 | DDS | 1,098 | Direct | COM | $133.01 | $146,050.36 | 40,616 |
| 02/08/2024 | DDS | 980 | Direct | COM | $134.19 | $131,508.65 | 39,631 |
| 02/06/2024 | DDS | 1,280 | Direct | COM | $142.12 | $181,910.02 | 38,751 |
| 01/31/2024 | DDS | 1,207 | Direct | COM | $140.78 | $169,926.77 | 37,601 |
| 08/21/2023 | DDS | 1,600 | Direct | COM | $107.40 | $171,836.00 | 36,436 |
| 02/08/2023 | DDS | 980 | Direct | COM | $104.12 | $102,036.03 | 34,381 |
| 02/07/2023 | DDS | 2,030 | Direct | COM | $102.29 | $207,643.02 | 19,705 |
| 02/07/2023 | DDS | 15,360 | Direct | COM | $102.42 | $1,573,224.96 | 33,501 |
| 02/06/2023 | DDS | 1,280 | Direct | COM | $105.63 | $135,200.77 | 17,879 |
| 01/31/2023 | DDS | 1,207 | Direct | COM | $109.95 | $132,710.25 | 16,729 |
| 01/06/2023 | DDS | 400 | Direct | COM | $125.00 | $50,000.00 | 15,643 |
| 11/30/2022 | DDS | 20,063 | Direct | COM | $125.90 | $2,525,965.81 | 15,643 |
| 11/30/2022 | DDS | 22,162 | Direct | COM | $125.90 | $2,790,233.48 | 15,643 |
| 11/30/2022 | DDS | 7,775 | Direct | COM | $125.90 | $978,885.72 | 15,643 |
| 11/10/2022 | DDS | 100 | Direct | COM | $125.36 | $12,536.20 | 15,643 |
| 1 2 3 Next Last You are at page 1 of 3 pages |
|
Transaction Type Key First letter: A = Acquired, D = Disposed Second letter: A = Grant, award or other acquisition pursuant to Rule 16b-3(d) C = Conversion of derivative security | D = Disposition to the issuer of issuer equity securities pursuant to Rule 16b-3(e) | E = Expiration of short derivative position | F = Payment of exercise price or tax liability by delivering or withholding securities incident to the receipt, exercise or vesting of a security issued in accordance with Rule 16b-3. | G = Gift | H = Expiration (or cancellation) of long derivative position with value received | I = Discretionary transaction in accordance with Rule 16b-3(f) | J = Other | L = Small acquisition under Rule 16a-6 | M = Exercise or conversion of derivative security exempted pursuant to Rule 16b-3 | O = Exercise of out-of-the-money derivative security | P = Open market or private purchase | S = Open market or private sale | U = Disposition pursuant to a tender of shares in a change of control transaction | W = Acquisition or disposition by will or the laws of descent and distribution | X = Exercise of in-the-money or at-the-money derivative security | Z = Deposit into or withdrawal from voting trust |
 |
Send to Excel |
© 2000 - 2025 Zacks Investment Research